Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Pikromycin

From Wikipedia, the free encyclopedia
(Redirected from Picromycin)
Pikromycin
Names
IUPAC name
(3R,5R,6S,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-6-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyloxy]-1-oxacyclotetradec-11-ene-2,4,10-trione
Systematic IUPAC name
(3R,5R,6S,7S,9R,11E,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-1-oxacyclotetradec-11-ene-2,4,10-trione
Other names
Picromycin
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
UNII
  • InChI=1S/C28H47NO8/c1-10-22-28(7,34)12-11-21(30)15(2)13-16(3)25(18(5)23(31)19(6)26(33)36-22)37-27-24(32)20(29(8)9)14-17(4)35-27/h11-12,15-20,22,24-25,27,32,34H,10,13-14H2,1-9H3/b12-11+/t15-,16+,17-,18+,19-,20+,22-,24-,25+,27+,28+/m1/s1 checkY
    Key: UZQBOFAUUTZOQE-VSLWXVDYSA-N checkY
  • InChI=1S/C28H47NO8/c1-10-22-28(7,34)12-11-21(30)15(2)13-16(3)25(18(5)23(31)19(6)26(33)36-22)37-27-24(32)20(29(8)9)14-17(4)35-27/h11-12,15-20,22,24-25,27,32,34H,10,13-14H2,1-9H3/b12-11+/t15-,16+,17-,18+,19-,20+,22-,24-,25+,27+,28+/m1/s1
  • O=C2[C@@H]([C@@H](O[C@@H]1O[C@@H](C[C@H](N(C)C)[C@H]1O)C)[C@@H](C)C[C@H](C(=O)/C=C/[C@@](O)(C)[C@H](OC(=O)[C@@H]2C)CC)C)C
Properties
C28H47NO8
Molar mass 525.683 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X markN verify (what is checkYX markN ?)

Pikromycin was studied by Brokmann and Hekel in 1951 and was the first antibiotic macrolide to be isolated.[1] Pikromycin is synthesized through a type I polyketide synthase system in Streptomyces venezuelae, a species of Gram-positive bacterium in the genus Streptomyces.[2] Pikromycin is derived from narbonolide, a 14-membered ring macrolide. [3] Along with the narbonolide backbone, pikromycin includes a desosamine sugar and a hydroxyl group. Although Pikromycin is not a clinically useful antibiotic, it can be used as a raw material to synthesize antibiotic ketolide compounds such as erythromycins and new epothilones. [4]

Biosynthesis

[edit]

The pikromycin polyketide synthase of Streptomyces venezuelae contains four polypeptides: PikAI, PikAII, PikAIII, and PikAIV. These polypeptides contain a loading module, six extension molecules, and a thioesterase domain that terminated the biosynthetic procedure. [5] Recently electron cryo-microscopy have been used to determine sub-nanometre-resolution three- dimensional reconstructions of a full-length PKS module from the bacterium Streptomyces venezuelae that revealed an unexpectedly different architecture. [6] In Figure 1, each circle corresponds to a PKS mutilifuctional protein, where ACP is acyl carrier protein, KS is keto-ACP synthase, KSQ is a keto-ACP synthase like domain, AT is acyltransferase, KR is keto ACP reductase, KR with cross is inactive KR, DH is hydroxyl-thioester dehydratase, ER is enoyl reductase, TEI is thioesterase domain I, TEII is type II thioesterase. [7] Des corresponds to the enzymes utilized in desosamine biosynthesis and transfer, which include DesI-DesVIII.[citation needed]

Figure 2 represents the desosamine deoxyamino sugar biosynthetic pathway. DesI-DesVI (des locus of pikromycin PKS) encodes all the enzymes needed to obtain TDP-desoamine from TDP-glucose. DesVII and DesVIII activities transfer desoamine to narbonolide and narbomycin is obtained. PikC cytochrome P450 hydrolase catalyzes the hydroxylation of narbomycin to obtain pikromycin. [2]

Figure 1: Domain organization of PKS for Narbonolide, a precursor of Pikromycin
Figure 2: Pikromycin Formation through the desosamine deoxyamino sugar biosynthetic pathway

See also

[edit]

References

[edit]
  1. Brockmann, H. & Henkel, W. (1951). "Pikromycin, ein bitter schmeckendes Antibioticum aus Actinomyceten". Ntibiotica aus Actinomyceten. 84: 184–288. doi:10.1002/cber.19510840306.
  2. 1 2 Y. Xue & D. Sherman (2001). "Biosynthesis and Combinatorial Biosynthesis of Pikromycin-Related Macrolides in Streptomyces venezuelae". Metabolic Engineering. 3 (1): 15–26. doi:10.1006/mben.2000.0167. PMID 11162229.
  3. Maezawa, T. Hori, A. Kinumaki and M. Suzuki (1973). "Biological conversion of narbonolide to picromycin". The Journal of Antibiotics. 26 (12): 771–775. doi:10.7164/antibiotics.26.771. PMID 4792390.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. J.D. Kittendorf & D.H. Sherman (2009). "The Methymycin/Pikromycin Biosynthetic Pathway: A Model for Metabolic Diversity in Natural Product". Bioorg Med Chem. 17 (6): 2137–2146. doi:10.1016/j.bmc.2008.10.082. PMC 2843759. PMID 19027305.
  5. S. Guptaa; V. Lakshmanan; B.S. Kima; R. Fecik & K. A. Reynolds (2008). "Generation of Novel Pikromycin Antibiotic Products Through Mutasynthesis". ChemBioChem. 9 (10): 1609–1616. doi:10.1002/cbic.200700635. PMC 2614871. PMID 18512859.
  6. S. Dutta; J. R. Whicher; D. A. Hansen; W. A. Hale; J. A. Chemler; G. R. Congdon; A. R. H. Narayan; K. Håkansson; D. H. Sherman; J. L. Smith; G. Skiniotis (2014). "Structure of amodular polyketide synthase". Nature. 510 (7506): 512–517. Bibcode:2014Natur.510..512D. doi:10.1038/nature13423. PMC 4278352. PMID 24965652.
  7. D.L. Akey; J.D. Kittendorf; J.W. Giraldes; R.A. Fecik; D.H. Sherman & J.L. Smith (2006). "Structural basis for macrolactonization by the pikromycin thioesterase". Nature Chemical Biology. 2 (10): 537–542. doi:10.1038/nchembio824. PMID 16969372. S2CID 6262508.